Walsh RC - Search Results

1

Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipients.

Schmidt N, Alloway RR, Walsh RC, Sadaka B, Shields AR, Girnita AL, Hanseman DJ, Woodle ES. Schmidt N, et al. Among authors: walsh rc. Transplantation. 2012 Aug 27;94(4):352-61. doi: 10.1097/TP.0b013e318257acf6. Transplantation. 2012. PMID: 22836132

2

Proteasome inhibitor therapy for antibody-mediated rejection.

Woodle ES, Walsh RC, Alloway RR, Girnita A, Brailey P. Woodle ES, et al. Among authors: walsh rc. Pediatr Transplant. 2011 Sep;15(6):548-56. doi: 10.1111/j.1399-3046.2011.01543.x. Pediatr Transplant. 2011. PMID: 21884344 Review.

3

Prospective iterative trial of proteasome inhibitor-based desensitization.

Woodle ES, Shields AR, Ejaz NS, Sadaka B, Girnita A, Walsh RC, Alloway RR, Brailey P, Cardi MA, Abu Jawdeh BG, Roy-Chaudhury P, Govil A, Mogilishetty G. Woodle ES, et al. Among authors: walsh rc. Am J Transplant. 2015 Jan;15(1):101-18. doi: 10.1111/ajt.13050. Am J Transplant. 2015. PMID: 25534446 Free article.

4

Proteasome inhibition for antibody-mediated rejection.

Everly JJ, Walsh RC, Alloway RR, Woodle ES. Everly JJ, et al. Among authors: walsh rc. Curr Opin Organ Transplant. 2009 Dec;14(6):662-6. doi: 10.1097/MOT.0b013e328330f304. Curr Opin Organ Transplant. 2009. PMID: 19667989 Review.

5

Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.

Walsh RC, Everly JJ, Brailey P, Rike AH, Arend LJ, Mogilishetty G, Govil A, Roy-Chaudhury P, Alloway RR, Woodle ES. Walsh RC, et al. Transplantation. 2010 Feb 15;89(3):277-84. doi: 10.1097/TP.0b013e3181c6ff8d. Transplantation. 2010. PMID: 20145517

6

Bortezomib-based treatment of antibody mediated rejection in pancreas allograft recipients.

Govil A, Walsh RC, Tevar A, Alloway R, Roy-Chaudhury P, Mogilishetty G, Wall GE, Brailey P, Girnita A, Woodle ES. Govil A, et al. Among authors: walsh rc. Clin Transpl. 2009:443-53. Clin Transpl. 2009. PMID: 20524313

7

Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition.

Walsh RC, Brailey P, Girnita A, Alloway RR, Shields AR, Wall GE, Sadaka BH, Cardi M, Tevar A, Govil A, Mogilishetty G, Roy-Chaudhury P, Woodle ES. Walsh RC, et al. Transplantation. 2011 Jun 15;91(11):1218-26. doi: 10.1097/TP.0b013e318218e901. Transplantation. 2011. PMID: 21617586

8

Proteasome inhibitor-based therapy for antibody-mediated rejection.

Walsh RC, Alloway RR, Girnita AL, Woodle ES. Walsh RC, et al. Kidney Int. 2012 Jun;81(11):1067-74. doi: 10.1038/ki.2011.502. Epub 2012 Feb 15. Kidney Int. 2012. PMID: 22336990 Free article. Review.

9

HLA-DQ barrier: effects on cPRA calculations.

Tambur AR, Leventhal JR, Walsh RC, Zitzner JR, Friedewald JJ. Tambur AR, et al. Among authors: walsh rc. Transplantation. 2013 Dec 27;96(12):1065-72. doi: 10.1097/TP.0b013e3182a452a5. Transplantation. 2013. PMID: 23995957

10

Donor-Specific HLA Antibodies in Living Versus Deceased Donor Liver Transplant Recipients.

Levitsky J, Kaneku H, Jie C, Walsh RC, Abecassis M, Tambur AR. Levitsky J, et al. Among authors: walsh rc. Am J Transplant. 2016 Aug;16(8):2437-44. doi: 10.1111/ajt.13757. Epub 2016 Mar 23. Am J Transplant. 2016. PMID: 26896194 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters